Esperion Therapeutics Inc.
Esperion Therapeutics, Inc. (ANN MURR) develops oral non‑statin LDL‑C lowering agents—NEXLETOL, NEXLIZET, NILEMDO, NUSTENDI—targeting high‑risk hyperlipidemia. Collaborative partnerships with Daiichi Sankyo and Otsuka support global commercial strategy.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- Employees: 304
- HQ: Ann Arbor
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.